Celiprolol Treatment in Patients with Vascular Ehlers-Danlos Syndrome.

CONCLUSION: Treatment with celiprolol is tolerated in most patients with vEDS. Despite fatal vascular events, these observations suggest that celiprolol may have a protective effect in vEDS. PMID: 33223285 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/33223285?dopt=Abstract

Source: PubMed: Eur J Vasc Endovasc ... - November 19, 2020 Category: Surgery Authors: Baderkhan H, Wanhainen A, Stenborg A, Stattin EL, Björck M Tags: Eur J Vasc Endovasc Surg Source Type: research